4582.T
Price:
$71
Market Cap:
$3.91B
SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan.
Industry
Medical - Pharmaceuticals
IPO Date
2011-10-20
Stock Exchange
JPX
Ticker
4582.T
According to SymBio Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.68. This represents a change of -35.16% compared to the average of -1.05 of the last 4 quarters.
The mean historical PE Ratio of SymBio Pharmaceuticals Limited over the last ten years is 1.68. The current -0.68 PE Ratio has changed -4142.46% with respect to the historical average. Over the past ten years (40 quarters), 4582.T's PE Ratio was at its highest in in the June 2021 quarter at 5.45K. The PE Ratio was at its lowest in in the March 2021 quarter at -51.50.
Average
1.68
Median
-2.90
Minimum
-5.02
Maximum
21.59
Discovering the peaks and valleys of SymBio Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 67.26%
Maximum Annual PE Ratio = 21.59
Minimum Annual Increase = -807.03%
Minimum Annual PE Ratio = -5.02
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.95 | -59.59% |
| 2024 | -2.34 | -53.38% |
| 2023 | -5.02 | -123.58% |
| 2022 | 21.29 | -1.37% |
| 2021 | 21.59 | -807.03% |
| 2020 | -3.05 | -4.92% |
| 2019 | -3.21 | -30.06% |
| 2018 | -4.59 | 67.26% |
| 2017 | -2.74 | -33.83% |
| 2016 | -4.15 | 45.30% |
The current PE Ratio of SymBio Pharmaceuticals Limited (4582.T) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-2.77
5-year avg
6.91
10-year avg
1.68
SymBio Pharmaceuticals Limited’s PE Ratio is greater than Modalis Therapeutics Corporation (-1.37), less than WDB coco Co., Ltd. (0.96), greater than Nippon Chemiphar Co., Ltd. (-46.13), greater than MedRx Co., Ltd (-4.64), greater than Cyfuse Biomedical K.K. (-6.26), greater than Delta-Fly Pharma, Inc. (-0.78), greater than PRISM BioLab Co.,LTD (-6.35), less than ASO International, Inc. (13.36), greater than OncoTherapy Science, Inc. (-8.47), greater than Solasia Pharma K.K. (-9.35),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.37 | $3.18B | |
| 0.96 | $6.25B | |
| -46.13 | $5.74B | |
| -4.64 | $3.92B | |
| -6.26 | $5.65B | |
| -0.78 | $1.51B | |
| -6.35 | $6.14B | |
| 13.36 | $6.94B | |
| -8.47 | $7.97B | |
| -9.35 | $9.01B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SymBio Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SymBio Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is SymBio Pharmaceuticals Limited's PE Ratio?
How is the PE Ratio calculated for SymBio Pharmaceuticals Limited (4582.T)?
What is the highest PE Ratio for SymBio Pharmaceuticals Limited (4582.T)?
What is the 3-year average PE Ratio for SymBio Pharmaceuticals Limited (4582.T)?
What is the 5-year average PE Ratio for SymBio Pharmaceuticals Limited (4582.T)?
How does the current PE Ratio for SymBio Pharmaceuticals Limited (4582.T) compare to its historical average?